Splenic disorders in internal medicines

Authors

  • J. Rojo Álvaro Servicio de Medicina Interna. Complejo Hospitalario de Navarra A
  • F.J. Anniccherico Sánchez Servicio de Medicina Interna. Complejo Hospitalario de Navarra A
  • J.L. Alonso Martínez Servicio de Medicina Interna. Complejo Hospitalario de Navarra A
  • S. Pérez Ricarte Servicio de Medicina Interna. Complejo Hospitalario de Navarra A
  • J. Oteiza Olaso Servicio de Medicina Interna. Complejo Hospitalario de Navarra A
  • J.M. Casas Fernández de Tejerina Servicio de Medicina Interna. Complejo Hospitalario de Navarra A

DOI:

https://doi.org/10.23938/ASSN.0366

Keywords:

Spleen. Splenomegaly. Hypersplenism. Splenectomy.

Abstract

The spleen is the largest lymphopoietic organ, containing 25% of total lymphoid mass. It participates in cellular and humoral immunity and intervenes in the renovation of red cells and the elimination of bacteria. Splenic functions are reduced when the spleen is absent, which entails, amongst other complications, greater susceptibility to suffering from sepsis due to encapsulated organisms.

We present 6 clinical cases admitted to the Internal Medicine serve with splenic pathology and we make a review of the approach to be used.

The spectrum of splenic lesions in internal medicine is very wide. On occasions, a splenic pathology can be suspected due to clinical history, physical exploration or because of cytopenias in the analyses. Different complementary tests are available for completing study of these lesions. A splenectomy can be carried out in case of diagnostic doubt, with the most frequent diagnoses being hepatic cirrhosis and lymphoma/leukaemia.

Downloads

Download data is not yet available.

Author Biography

J. Rojo Álvaro, Servicio de Medicina Interna. Complejo Hospitalario de Navarra A

NULL

References

1. WILKINS BS. The spleen. Br J Haematol 2002; 117: 265-274.

https://doi.org/10.1046/j.1365-2141.2002.03425.x

2. RODEGHIERO F, RUGGERI M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012; 158: 16-29.

https://doi.org/10.1111/j.1365-2141.2012.09146.x

3. DI SABATINO A, CARSETTI R, CORAZZA GR. Post-splenectomy and hyposplenic states. Lancet 2011; 378: 86-97.

https://doi.org/10.1016/S0140-6736(10)61493-6

4. LAMMERS AJ, DE PORTO AP, BENNINK RJ, VAN LEEUWEN EM, BIEMOND BJ, GOSLINGS JC et al. Hyposplenism: comparison of different methods for determining splenic function. Am J Hematol 2012; 87: 484-489.

https://doi.org/10.1002/ajh.23154

5. PRENDKI V, NDOUR PA, JAIS X, CICERON L, SETTEGRANA C, BUFFET P. Reduced deformability of circulating erythrocytes: a marker of hyposplenism. Am J Hematol 2012; 87: E81-82.

https://doi.org/10.1002/ajh.23297

6. EBRIGHT JR, ALAM E, AHMED H, TUCKER R, ABRAMS J, LEVINE D. Splenic infarction and abscess in the setting of infective endocarditis. Infect Dis Clin Pract 2007; 15: 17-21.

https://doi.org/10.1097/IPC.0b013e31802b6894

7. LAWRENCE YR, POKROY R, BERLOWITZ D, AHARONI D, HAIN D, BREUER GS. Splenic infarction: an update on William Osler's observations. Isr Med Assoc J 2010; 12: 362-365.

8. CHUN YS, ROBU VG. Spectrum of primary vascular neoplasms of the spleen. J Clin Oncol 2011; 29: e116-117.

https://doi.org/10.1200/JCO.2010.31.7230

9. COMPÉRAT E, BARDIER-DUPAS A, CAMPARO P, CAPRON F, CHARLOTTE F. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med 2007; 131: 965-969.

https://doi.org/10.5858/2007-131-965-SMCPDD

10. MONTERROSO J, CHANDANA S. Images in clinical medicine. Massive splenomegaly in hairy-cell leukemia. N Engl J Med 2012; 367: 2133.

https://doi.org/10.1056/NEJMicm1013222

11. IANNITTO E, TRIPODO C. How I diagnose and treat splenic lymphomas. Blood 2011; 117: 2585-2595.

https://doi.org/10.1182/blood-2010-09-271437

12. MAKRIN V, AVITAL S, WHITE I, SAGIE B, SZOLD A. Laparoscopic splenectomy for solitary splenic tumors. Surg Endosc 2008; 22: 2009-2012.

https://doi.org/10.1007/s00464-008-0024-8

13. POTTAKKAT B, KASHYAP R, KUMAR A, SIKORA SS, SAXENA R, KAPOOR VK. Redefining the role of splenectomy in patients with idiopathic splenomegaly. ANZ J Surg 2006; 76: 679-682.

https://doi.org/10.1111/j.1445-2197.2006.03828.x

14. MCINNES MD, KIELAR AZ, MACDONALD DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology 2011; 260: 699-708.

https://doi.org/10.1148/radiol.11110333

15. DEEB AP, KIM MJ, FLEMING FJ, MESSING S, GUNZLER D, MONSON JR et al. The impact of operative approach in elective splenectomy: a multivariate analysis of outcomes from the NSQIP database. Surg Laparosc Endosc Percutan Tech 2012; 22: 415-419.

https://doi.org/10.1097/SLE.0b013e31825cba10

16. QU Y, REN S, LI C, QIAN S, LIU P. Management of postoperative complications following splenectomy. Int Surg 2013; 98: 55-60.

https://doi.org/10.9738/CC63.1

17. BICKENBACH KA, GONEN M, LABOW DM, STRONG V, HEANEY ML, ZELENETZ AD et al. Indications for and efficacy of splenectomy for haematological disorders. Br J Surg 2013; 100: 794-800.

https://doi.org/10.1002/bjs.9067

Published

2014-04-30

How to Cite

1.
Rojo Álvaro J, Anniccherico Sánchez F, Alonso Martínez J, Pérez Ricarte S, Oteiza Olaso J, Casas Fernández de Tejerina J. Splenic disorders in internal medicines. An Sist Sanit Navar [Internet]. 2014 Apr. 30 [cited 2025 Dec. 6];37(1):169-76. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/23949

Issue

Section

Clinical notes

Most read articles by the same author(s)